Cargando…
Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity
Alexander disease (AxD) is a fatal neurodegenerative disorder caused by mutations in glial fibrillary acidic protein (GFAP), which supports the structural integrity of astrocytes. Over 70 GFAP missense mutations cause AxD, but the mechanism linking different mutations to disease-relevant phenotypes...
Autores principales: | Battaglia, Rachel A, Beltran, Adriana S, Delic, Samed, Dumitru, Raluca, Robinson, Jasmine A, Kabiraj, Parijat, Herring, Laura E, Madden, Victoria J, Ravinder, Namritha, Willems, Erik, Newman, Rhonda A, Quinlan, Roy A, Goldman, James E, Perng, Ming-Der, Inagaki, Masaki, Snider, Natasha T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927689/ https://www.ncbi.nlm.nih.gov/pubmed/31682229 http://dx.doi.org/10.7554/eLife.47789 |
Ejemplares similares
-
Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation
por: Chen, Mei-Hsuan, et al.
Publicado: (2013) -
Effects of Alexander disease–associated mutations on the assembly and organization of GFAP intermediate filaments
por: Yang, Ai-Wen, et al.
Publicado: (2022) -
CSF and Blood Levels of GFAP in Alexander Disease
por: Jany, Paige L., et al.
Publicado: (2015) -
Refining the concept of GFAP toxicity in Alexander disease
por: Messing, Albee
Publicado: (2019) -
Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model
por: Lee, So-Hyun, et al.
Publicado: (2017)